"I stand by my words," says Dr. James Phillips, the Walter Reed physician who said the president's decision to drive by supporters while being treated for COVID-19 endangered his security detail.
5 Best CBD Oils for Pain Anne Harding
Replay Video
CBD oil for pain
Most people who use cannabidiol, or CBD, take CBD oil for chronic pain or joint pain. That s according to a 2018 study of more than 2,400 people published in
Cannabis and Cannabinoid Research that found CBD is used as a therapy for a wide range of conditions, from anxiety to sleep disorders.
Some people believe that CBD acts as a better therapeutic alternative for pain that hasn t responded well to traditional therapies. (Here s what you need to know about CBD for dental pain and anxiety.)
While the evidence that CBD is an effective pain reliever in humans is still accumulating, lab and animal studies show that it has anti-inflammatory effects. It also acts on serotonin receptors, opioid receptors, and other receptors involved in our pain response.
E-Mail
The uncertainty and confusion caused by the COVID-19 pandemic is being widely exploited by terror groups for spinning a plethora of sinister schemes , which could lead to a new tide of violence against people and governments.
This is the claim of a new international study published in the peer-reviewed
Global Security: Health, Science and Policy, which analysed terrorist activity and trends across the globe since the pandemic began. Despite the overriding media attention to the COVID-19 pandemic and its near-total eclipse of security issues, the terrorism milieu has hardly taken a pause from its deadly pursuits or suspended the execution of its plans, lead author Professor of Psychology Arie Kruglanski from the University of Maryland, explains.
Largest Kidney Group Thanks President Trump For Signing Pandemic Relief And Transplant Drug Coverage
Transplant Drug Reform A Milestone in First Year of AAKP s Decade of the Kidney™
News provided by
Share this article
Share this article
WASHINGTON, Dec. 27, 2020 /PRNewswire/ The American Association of Kidney Patients (AAKP), the largest and oldest kidney patient organization in the United States, released the following statement upon President Donald J. Trump s signing of bipartisan, Congressionally authorized immunosuppressive drug coverage provisions for kidney transplant patients. The provisions were included in Congressional actions related to the COVID-19 pandemic relief package and $1.4 trillion omnibus spending bill. AAKP patient volunteers used the organization s sophisticated communications systems to drive Congressional action and mobilize the most comprehensive national grassroots campaign in its 50-year history, the effort included, coordinated local virtual kid